ИСТИНА

Sharpsten Lucie

Соавторы: McMurray J.J., Parkhomenko A.V., Solomon S., Teerlink J.R., Vinereanu D., Мареев В.Ю., Adam K., Arias-Mendoza A., Arias‐Mendoza A., Bhm M., Biering-Sørensen T., Biering‐Sørensen T., Bonderman D. показать полностью..., Cleland J.G., Corbalan R., Crespo-Leiro M.G., Dahlström U., Dahlström U., Echeverria Correa L.E., Fait A., Felder G., Fonseca C., Goncalvesova E., Goncalvesova E., Howlett J., J M., LOZANO R., Lanfear D.E., Lanfear D.E., Lund M., Lund M., Ma R., Malik S.K., Momomura S., Momomura S., O’Toole E., Pinar A.B., Ponikowski P., Rafael G.T., SLIWA K., Sauter O., Tomcsanyi J., Tomcsanyi J., Vandekerckhove C., Voors A.A.

2 статьи

Количество цитирований статей в журналах по данным Web of Science: 180, Scopus: 206

IstinaResearcherID (IRID): 345208424

Деятельность

• Статьи в журналах

  • 
    • 2021 Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
    • Teerlink John R., Diaz Rafael, Felker G.Michael, McMurray John J.V., Metra Marco, Solomon Scott D., Adams Kirkwood F., Anand Inder, Arias-Mendoza Alexandra, Biering-Sørensen Tor, Böhm Michael, Bonderman Diana, Cleland John G.F., Corbalan Ramon, Crespo-Leiro Maria G., Dahlström Ulf, Echeverria Luis E., Fang James C., Filippatos Gerasimos, Fonseca Cândida, Goncalvesova Eva, Goudev Assen R., Howlett Jonathan G., Lanfear David E., Li Jing, Lund Mayanna, Macdonald Peter, Mareev Viacheslav, Momomura Shin-ichi, O’Meara Eileen, Parkhomenko Alexander, Ponikowski Piotr, Ramires Felix J.A., Serpytis Pranas, Sliwa Karen, Spinar Jindrich, Suter Thomas M., Tomcsanyi Janos, Vandekerckhove Hans, Vinereanu Dragos, Voors Adriaan A., Yilmaz Mehmet B., Zannad Faiez, Sharpsten Lucie, Legg Jason C., Varin Claire, Honarpour Narimon, Abbasi Siddique A., Malik Fady I., Kurtz Christopher E.
    • в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 384, с. 105-116 DOI
  • 
    • 2020 Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials
    • Teerlink John R., Diaz Rafael, Felker G.Michael, McMurray John J.V., Metra Marco, Solomon Scott D., Adams Kirkwood F., Anand Inder, Arias‐Mendoza Alexandra, Biering‐Sørensen Tor, Böhm Michael, Bonderman Diana, Cleland John G.F., Corbalan Ramon, Crespo‐Leiro Maria G., Dahlström Ulf, Echeverria Correa Luis E., Fang James C., Filippatos Gerasimos, Fonseca Cândida, Goncalvesova Eva, Goudev Assen R., Howlett Jonathan G., Lanfear David E., Lund Mayanna, Macdonald Peter, Mareev Vyacheslav, Momomura Shin‐ichi, O'Meara Eileen, Parkhomenko Alexander, Ponikowski Piotr, Ramires Felix J.A., Serpytis Pranas, Sliwa Karen, Spinar Jindrich, Suter Thomas M., Tomcsanyi Janos, Vandekerckhove Hans, Vinereanu Dragos, Voors Adriaan A., Yilmaz Mehmet B., Zannad Faiez, Sharpsten Lucie, Legg Jason C., Abbasi Siddique A., Varin Claire, Malik Fady I., Kurtz Christopher E.
    • в журнале European Journal of Heart Failure, издательство Elsevier BV (Netherlands), том 22, № 11, с. 2160-2171 DOI